Pemphigus vulgaris is a rare autoimmune disease that causes painful blisters and erosions on the skin and mucous membranes, particularly inside the mouth.

Because pemphigus vulgaris involves abnormal immune responses and autoantibodies against cell-adhesion proteins, researchers rely on well-characterized patient-derived biospecimens to study disease mechanisms, biomarkers, immune responses, and potential treatments.

At Bay Biosciences, we understand the importance of clinically characterized specimens for autoimmune disease research.

We provide high-quality pemphigus vulgaris biospecimens, including human serum, plasma, and blood samples, as well as other human samples for research and development.

Understanding Pemphigus Vulgaris

Pemphigus vulgaris is an autoimmune blistering disorder in which the immune system produces antibodies that target proteins involved in the adhesion of skin and mucosal cells.

In particular, autoantibodies against desmoglein 3 can disrupt the connections between keratinocytes and lead to blister formation. Some patients also have antibodies against desmoglein 1.

The disease can affect the skin, oral cavity, and other mucosal surfaces. Oral lesions are common and may occur before skin involvement. The resulting erosions can cause pain and difficulty eating or drinking.

Signs and Symptoms of Pemphigus Vulgaris

The clinical presentation of pemphigus vulgaris can vary between patients. The disease commonly affects mucous membranes and may later involve the skin.

Common signs and symptoms include:

  • Painful blisters and erosions
  • Oral ulcers and erosions
  • Difficulty eating or drinking
  • Skin blisters that rupture easily
  • Painful or irritated skin lesions
  • Lesions on the scalp, face, chest, or back
  • Involvement of other mucosal surfaces
  • Hoarseness or difficulty swallowing when the throat or larynx is involved

Causes of Pemphigus Vulgaris

The exact reason why the immune system begins producing pathogenic autoantibodies in pemphigus vulgaris is not completely understood.

However, we do know that the disease results from an autoimmune response directed against proteins involved in epithelial cell adhesion.

Autoantibodies against desmoglein 3 interfere with the normal adhesion between keratinocytes, resulting in acantholysis and intraepidermal blister formation.

Certain medications, infections, trauma, and other biological factors have been associated with pemphigus in some individuals.

Risk Factors for Pemphigus Vulgaris

Several factors have been associated with an increased risk of pemphigus vulgaris or specific forms of pemphigus.

Firstly, age may influence disease occurrence, with pemphigus vulgaris commonly developing during adulthood.

Secondly, genetic susceptibility may contribute to the development of autoimmune disease. Certain populations have a higher reported frequency of pemphigus vulgaris, suggesting that genetic factors may influence susceptibility.

Thirdly, medication exposure has been associated with drug-induced pemphigus.

Reported medications include certain penicillamine, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and cephalosporins.

However, it is important to mention that many patients do not have a clearly identifiable trigger. Therefore, continued research using autoimmune disease samples can help researchers better understand the factors involved in disease initiation and progression.

Diagnosis of Pemphigus Vulgaris

Diagnosis generally begins with a clinical examination and evaluation of the patient’s skin and mucosal lesions.

A biopsy is commonly performed to examine affected tissue under a microscope.

Histopathological examination can identify characteristic suprabasal blister formation and acantholysis.

Direct immunofluorescence is an important diagnostic test because it can demonstrate intercellular deposits of immunoglobulin G (IgG) and/or complement within the epidermis, producing a characteristic pattern.

Blood-based testing adds further support by identifying circulating autoantibodies. In particular, enzyme-linked immunosorbent assays (ELISAs) can detect antibodies against desmoglein 1 and desmoglein 3 in many patients.

Because these antibodies circulate in the blood, human serum samples and human plasma samples are valuable materials for researchers investigating autoantibodies and other biomarkers associated with pemphigus vulgaris.

Treatment of Pemphigus Vulgaris

Treatment aims to control autoimmune activity, reduce blister formation, promote healing, and prevent complications.

Systemic corticosteroids have historically been a major component of treatment.

Depending on the patient’s disease characteristics, physicians may also use steroid-sparing immunosuppressive or immunomodulatory therapies.

Rituximab is an established treatment option for pemphigus vulgaris, while other therapies may be considered depending on the clinical situation.

Topical corticosteroids may be used for localized skin disease, while appropriate wound care can help manage erosions.

Oral lesions may require specific topical treatment and supportive care.

Applications of Pemphigus Vulgaris Samples for Research

Well-characterized pemphigus vulgaris samples can support a wide range of studies involving autoimmune mechanisms, biomarkers, disease activity, and therapeutic development.

Pemphigus Vulgaris Biospecimens

Pemphigus vulgaris biospecimens can include blood-derived materials such as serum and plasma, as well as other patient-derived specimens. These materials help researchers investigate circulating autoantibodies and other biological markers associated with disease.

Autoimmune Disease Samples

Autoimmune disease samples can be used to compare immune biomarkers across different autoimmune conditions. Researchers may use appropriately characterized specimens to investigate disease-specific and shared immune pathways.

Human Serum Samples

Human serum samples from patients with pemphigus vulgaris support investigations of circulating antibodies and other soluble biomarkers. Serum-based studies can help researchers evaluate relationships between immune markers and disease characteristics.

Human Plasma Samples

Human plasma samples can provide a blood-derived research material for studying circulating proteins, antibodies, nucleic acids, and other analytes. Researchers can use plasma in biomarker discovery and immunological studies when the specimen characteristics match their research requirements.

Frequently Asked Questions

Is pemphigus vulgaris contagious?

No. It is an autoimmune condition and cannot spread through touch or sharing food or personal items.

What are pemphigus vulgaris samples for research?

Pemphigus vulgaris samples are patient-derived specimens collected from individuals with pemphigus vulgaris. Depending on study requirements, these may include human serum samples, human plasma samples, human blood samples, and other biospecimen formats.

Are research samples ethically sourced?

Yes. All biospecimens available on our website are sourced with ethical guidelines in mind.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we provide high-quality human biospecimens for pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers.

Our samples help support research involving pemphigus vulgaris, autoimmune mechanisms, biomarker discovery, inflammatory disease, and therapeutic development.

Our range of specimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.